155 related articles for article (PubMed ID: 1979984)
1. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis.
Marciano-D'Amore DA; Paterson WG; Da Costa LR; Beck IT
J Clin Gastroenterol; 1990 Dec; 12(6):616-20. PubMed ID: 1979984
[TBL] [Abstract][Full Text] [Related]
2. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis.
Koop H; Arnold R
Dig Dis Sci; 1991 May; 36(5):552-7. PubMed ID: 1673654
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists.
Koop H; Hotz J; Pommer G; Klein M; Arnold R
Aliment Pharmacol Ther; 1990 Dec; 4(6):593-9. PubMed ID: 1983342
[TBL] [Abstract][Full Text] [Related]
4. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview.
Chiba N
Can J Gastroenterol; 1997 Sep; 11 Suppl B():66B-73B. PubMed ID: 9347181
[TBL] [Abstract][Full Text] [Related]
6. Healing and relapse of severe peptic esophagitis after treatment with omeprazole.
Hetzel DJ; Dent J; Reed WD; Narielvala FM; Mackinnon M; McCarthy JH; Mitchell B; Beveridge BR; Laurence BH; Gibson GG
Gastroenterology; 1988 Oct; 95(4):903-12. PubMed ID: 3044912
[TBL] [Abstract][Full Text] [Related]
7. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy.
Klinkenberg-Knol EC; Meuwissen SG
Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868
[TBL] [Abstract][Full Text] [Related]
8. Treatment of reflux oesophagitis resistant to H2-receptor antagonists.
Klinkenberg-Knol EC; Meuwissen SG
Digestion; 1989; 44 Suppl 1():47-53. PubMed ID: 2575061
[TBL] [Abstract][Full Text] [Related]
9. [Conservative treatment of florid peptic esophageal stenosis. Complete elimination by dilatation and omeprazole in H2-blocker refractory cases].
Koop H; Katschinski M; Arnold R
Med Klin (Munich); 1991 Nov; 86(11):566-8. PubMed ID: 1685214
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
Lundell L; Backman L; Ekström P; Enander LH; Fausa O; Lind T; Lönroth H; Sandmark S; Sandzén B; Unge P
Aliment Pharmacol Ther; 1990 Apr; 4(2):145-55. PubMed ID: 1983321
[TBL] [Abstract][Full Text] [Related]
11. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.
Klinkenberg-Knol EC; Festen HP; Jansen JB; Lamers CB; Nelis F; Snel P; Lückers A; Dekkers CP; Havu N; Meuwissen SG
Ann Intern Med; 1994 Aug; 121(3):161-7. PubMed ID: 8017742
[TBL] [Abstract][Full Text] [Related]
13. Reflux esophagitis.
Tytgat GN; Nio CY; Schotborgh RH
Scand J Gastroenterol Suppl; 1990; 175():1-12. PubMed ID: 1978403
[TBL] [Abstract][Full Text] [Related]
14. A comparison of five maintenance therapies for reflux esophagitis.
Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
[TBL] [Abstract][Full Text] [Related]
15. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery.
Fiasse R; Druez P; Coppens JP; Delhaze M; Fabre C; Pauwels S; Dive C
Acta Gastroenterol Belg; 1990; 53(5-6):573-84. PubMed ID: 2130587
[TBL] [Abstract][Full Text] [Related]
17. Omeprazole in infants with cimetidine-resistant peptic esophagitis.
Alliët P; Raes M; Bruneel E; Gillis P
J Pediatr; 1998 Feb; 132(2):352-4. PubMed ID: 9506656
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
McTavish D; Buckley MM; Heel RC
Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists.
Tytgat GN; Lamers CB; Hameeteman W; Jansen JM; Wilson JA
Aliment Pharmacol Ther; 1987 Feb; 1(1):31-8. PubMed ID: 2908747
[TBL] [Abstract][Full Text] [Related]
20. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists.
Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Snel P; Meuwissen SG
Scand J Gastroenterol Suppl; 1989; 166():88-93; discussion 94. PubMed ID: 2574911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]